Thus, in the work of de Wispelaere et al. [24], a proteolysis targeting chimera (PROTAC) based on a hepatitis C virus NS3/4A protease inhibitor led to target degradation and inhibition of viral infection in cells. The gene discussed is KRAS; the disease is viral infectious disease.